期刊文献+

动态增强MR参数SS与微血管密度在乳腺癌中的相关性研究及临床意义 被引量:1

Correlative study and clinical significance of parameter SS of dynamic contrast-enhanced MR and microvessel density in breast carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨乳腺癌磁共振(MR)动态增强扫描的曲线最大增强线性斜率(SS)和组织微血管密度(MVD)的关系及二者的临床意义。方法:对58例原发性乳腺癌患者术前行动态增强MR扫描,根据时间-信号强度曲线计算出参数SS值,术后采用免疫组化方法检测乳腺癌组织中MVD情况,结合病理淋巴结转移情况加以分析。结果:38例淋巴结转移阳性组的MVD均数为52.75±13.87,SS均数为6.15±1.23(%/s),而阴性组的MVD和SS分别为38.23±11.45和2.48±1.12,二者相比均具有显著性差异(P值均(0.05);且SS与MVD呈明显正相关关系(r=0.812,P<0.05)。结论:MVD和SS均可作为判断乳腺癌淋巴结转移的预测因子和判断预后的指标,并且SS在术前能一定程度上反映乳腺癌的血管生成特征,较病理组织学方法更优越。 Objective:To investigate the relationship and clinical significance between steepest slope (SS) of dynamic contrast - enhanced magnetic resonance (MR) and histological microvessel density ( MVD ) in breast carcinoma. Methods: Total of 58 patients with breast carcinoma were underwent dynamic contrast - enhanced MR scanning before operation. The parameters SS and MVD were calculated based on time - signal intensity curves and immunohistochemical staining technique. The correlations of lymphatic involvement and SS as well as MVD were analyzed. Results: Tumors with axillary lymphatic involvement( n = 38) (MVD = 52.75 ± 13.87/HP; SS = 6.15 ± 1.23/%/ s)had significantly higher values of both SS and MVD than those without axillary lymphatic involvement(n = 20) ( MVD = 38.23 ± 11.45 /HP ; SS = 2.48 ±1.12/%/s) ( P 〈 0.05 ). Conclusion: SS and MVD had correlation with lymphatic involvement of breast carcinoma, and could be used to predict lymphatic involvement and prognosis. Especially, SS is more predominate than MVD in evaluating the microvessel conditions of breast carcinoma before oprations.
出处 《现代肿瘤医学》 CAS 2009年第2期245-248,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(30672420) 哈尔滨医科大学附属第二医院青年基金项目(QN2008-12)
关键词 乳腺癌 微血管密度 MR动态增强 曲线最大增强线性斜率 淋巴转移 breast carcinoma microvessel density dynamic contrast - enhanced MR steepest slope lymphatic metastasis
作者简介 仲雷(1980-),男,山东乐陵人,医师,硕士,主要从事乳腺疾病的基础与临床研究。 [通讯作者]刁群超(1975-),男,黑龙江人,主治医师,硕士,主要从事肿瘤MR成像研究。
  • 相关文献

参考文献3

二级参考文献23

  • 1刘士远,肖湘生.磁共振信号强度区分肺癌组织类型的可行性研究[J].中华放射学杂志,1996,30(4):245-248. 被引量:15
  • 2Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significent and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84:1875-1887.
  • 3Augustin HG. Angiogenic tumor therapy: will it work? Trends Pharmacol Sci, 1998, 19:216-222.
  • 4Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor.Endocr Rev,1987, 8:95-114.
  • 5Van der Zee R, Murohara T, Lao Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation, 1997,95 : 1030-1037.
  • 6Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res, 1994, 85:1045-1049.
  • 7Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 1992,23:755-761.
  • 8Van Hoef ME, Knox WF, Dhesi SS, et al. Assessment of tumour vascularity as a prognostic fator in lymph node negative invasive breast cancer. Eur J Cancer, 1993,29A:1141-1145.
  • 9Medri L, Nanni O, Volpi A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer, 2000,89:74-80.
  • 10Kerslake RW, Carleton PJ, Fox JN, et al. Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast[J]. Clin Radiol,1995,50(7): 440-454.

共引文献122

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部